person · Reporting owner
Valauri Christina Rizopoulos
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Precipio, Inc.PRPO · Entity 7207 | Director | July 15, 2026 | July 16, 2026 |
| Valion Bio, Inc.TIVC · Entity 8459 | Director | April 01, 2026 | April 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Precipio, Inc.
Report date July 15, 2026 · Filed July 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,628 |
Reported balance
After 2026-07-15 transaction · row 1
1 source rowRow 1 · 2026-07-15 · Grant · Acquired 108 · Balance 5,628 F1: 108 shares of common stock were granted upon the close of business on July 15, 2026, as a consideration in lieu of cash payment of compensation for service as a member of the Board of Directors for Q2-26. |
Filing footnotes · ownership attribution and instrument terms
F1: 108 shares of common stock were granted upon the close of business on July 15, 2026, as a consideration in lieu of cash payment of compensation for service as a member of the Board of Directors for Q2-26.
Valion Bio, Inc.
Report date April 01, 2026 · Filed April 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 19,000 |
Reported balance
After 2026-04-01 transaction · row 1
1 source rowRow 1 · 2026-04-01 · Purchase · Acquired 19,000 · Balance 19,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 15, 2026 Filed Jul 16, 2026 20:32 UTC | Precipio, Inc. PRPO · Entity 7207 | GrantCommon Stock | 108 | $25.24 | $2,725.92 |
DisclosureSEC source: 0001104659-26-084267 · tm2620684-3_4seq1.xml · nonDerivative · entry 1 Valauri Christina Rizopoulos · CIK 0002005448 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,628 F1 · shares: 108 shares of common stock were granted upon the close of business on July 15, 2026, as a consideration in lieu of cash payment of compensation for service as a member of the Board of Directors for Q2-26. Read SEC document |
| April 15, 2026 Filed Apr 17, 2026 21:01 UTC | Precipio, Inc. PRPO · Entity 7207 | GrantCommon Stock | 93 | $29.49 | $2,742.57 |
DisclosureSEC source: 0001104659-26-044959 · tm2612069-3_4seq1.xml · nonDerivative · entry 1 Valauri Christina Rizopoulos · CIK 0002005448 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,520 F1 · shares: 93 shares of common stock were granted upon the close of business on April 15, 2026, as a consideration in lieu of cash payment of compensation for service as a member of the Board of Directors for Q1-25. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 13:49 UTC | Valion Bio, Inc. TIVC · Entity 8459 | PurchaseCommon Stock | 19,000 | $0.95 | $18,008.20 |
DisclosureSEC source: 0001683168-26-002599 · ownership.xml · nonDerivative · entry 1 Valauri Christina Rizopoulos · CIK 0002005448 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,000 Read SEC document |
| January 15, 2026 Filed Jan 20, 2026 21:15 UTC | Precipio, Inc. PRPO · Entity 7207 | GrantCommon Stock | 406 | $24.00 | $9,744.00 |
DisclosureSEC source: 0001104659-26-005039 · tm263642-1_4seq1.xml · nonDerivative · entry 1 Valauri Christina Rizopoulos · CIK 0002005448 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,427 F1 · price: 406 shares of common stock were granted upon the close of business on January 15, 2026, as a consideration in lieu of cash payment of compensation for service as a member of the Board of Directors for Q4-25. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:35 UTC | Precipio, Inc. PRPO · Entity 7207 | GrantStock Option (Right to Buy) · Derivative | 1,500 | $0.00 Strike: $23.82 | $0.00 |
DisclosureSEC source: 0001104659-26-001358 · tm261953-9_4seq1.xml · derivative · entry 1 Valauri Christina Rizopoulos · CIK 0002005448 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 1,500 shares Expires 2036-01-02 F2 · price: The stock option was granted pursuant to the Issuer's Equity Incentive Plan in consideration for the Reporting Person's service as a director of the Issuer and has an exercise price of $23.82 per share. F1 · derivative.exercise_date: The options shall vest in twelve equal monthly installments beginning on the one-month anniversary of the date of the issuance. Read SEC document |
| August 06, 2025 Filed Aug 8, 2025 22:46 UTC | Valion Bio, Inc. TIVC · Entity 8459 | GrantStock Option (Right to Purchase) · Derivative | 7,500 | $0.00 Strike: $3.32 | $0.00 |
DisclosureSEC source: 0001683168-25-005835 · ownership.xml · derivative · entry 1 Valauri Christina Rizopoulos · CIK 0002005448 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2035-08-05 F1 · derivative.exercise_date: The stock option vests in a series of four (4) successive equal quarterly installments, rounded downward to the nearest whole share, measured from the grant date, such that 100% of the stock option will be vested upon the first anniversary of the grant date. Read SEC document |
| January 14, 2025 Filed Jan 16, 2025 22:19 UTC | Precipio, Inc. PRPO · Entity 7207 | GrantStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $6.06 | $0.00 |
DisclosureSEC source: 0001104659-25-004172 · tm253548-11_4seq1.xml · derivative · entry 1 Valauri Christina Rizopoulos · CIK 0002005448 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2035-01-14 F2 · price: Issued pursuant to the Issuer's Equity Incentive Plan in consideration for the Reporting Person's service as a director of the Issuer. F1 · derivative.exercise_date: The options shall vest in twelve equal monthly installments beginning on the one-month anniversary of the date of the issuance. Read SEC document |
| December 18, 2024 Filed Dec 20, 2024 22:15 UTC | Valion Bio, Inc. TIVC · Entity 8459 | GrantStock Option (Right to Purchase) · Derivative | 12,000 | $0.00 Strike: $0.23 | $0.00 |
DisclosureSEC source: 0001683168-24-008897 · ownership.xml · derivative · entry 1 Valauri Christina Rizopoulos · CIK 0002005448 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2034-12-17 F1 · derivative.exercise_date: The Option Shares will vest and become exercisable in a series of twelve (12) successive equal monthly installments, rounded downward to the nearest whole share, measured from the Vesting Commencement Date, such that 100% of the Option Shares will be vested and exercisable upon the first (1st) anniversary of the Vesting Commencement Date. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 20:38 UTC | Precipio, Inc. PRPO · Entity 7207 | GrantCommon Stock | 1,472 | $6.62 | $9,744.64 |
DisclosureSEC source: 0001104659-24-109556 · tm2426435-5_4seq1.xml · nonDerivative · entry 1 Valauri Christina Rizopoulos · CIK 0002005448 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,021 F1 · price: 1,472 shares of common stock were granted upon the close of business on October 15, 2024, as a consideration in lieu of cash payment of compensation for service as a member of the Board of Directors for Q3-24. Read SEC document |
| August 09, 2024 Filed Aug 13, 2024 21:52 UTC | Valion Bio, Inc. TIVC · Entity 8459 | GrantEmployee Stock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $0.41 | $0.00 |
DisclosureSEC source: 0000950170-24-096483 · ownership.xml · derivative · entry 1 Valauri Christina Rizopoulos · CIK 0002005448 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2034-08-08 F1 · derivative.exercise_date: The option vests in a series of twelve (12) successive equal monthly installments, rounded downward to the nearest whole share, from the grant date, such that 100% of the option will be vested upon the first anniversary of the grant date. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 20:31 UTC | Precipio, Inc. PRPO · Entity 7207 | GrantCommon Stock | 2,103 | $4.63 | $9,736.89 |
DisclosureSEC source: 0001104659-24-080219 · tm2419567-4_4seq1.xml · nonDerivative · entry 1 Valauri Christina Rizopoulos · CIK 0002005448 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,549 F1 · shares: 2,103 shares of common stock were granted upon the close of business on July 15, 2024, as a consideration in lieu of cash payment of compensation for service as a member of the Board of Directors for Q2-24. Read SEC document |
| June 21, 2024 Filed Jun 25, 2024 21:16 UTC | Precipio, Inc. PRPO · Entity 7207 | GrantStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $4.98 | $0.00 |
DisclosureSEC source: 0001104659-24-074815 · tm2418227-8_4seq1.xml · derivative · entry 1 Valauri Christina Rizopoulos · CIK 0002005448 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2034-06-21 F2 · price: Issued pursuant to the Issuer's Equity Incentive Plan in consideration for the Reporting Person's service as a director of the Issuer F1 · derivative.exercise_date: The options shall vest in twelve equal monthly installments beginning on the one-month anniversary of the date of the issuance Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 20:20 UTC | Precipio, Inc. PRPO · Entity 7207 | GrantCommon Stock | 1,446 | $6.74 | $9,746.04 |
DisclosureSEC source: 0001104659-24-048319 · tm2412083-1_4seq1.xml · nonDerivative · entry 1 Valauri Christina Rizopoulos · CIK 0002005448 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,446 F1 · price: 1,446 shares of common stock were granted upon the close of business on April 15, 2024, as a consideration in lieu of cash payment of deferred compensation for service as a member of the Board of Directors for Q1-24. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:33 UTC | Precipio, Inc. PRPO · Entity 7207 | GrantEmployee Stock Option (right to buy) · Derivative | 259 | $0.00 Strike: $6.52 | $0.00 |
DisclosureSEC source: 0001104659-24-001395 · tm242086-2_4seq1.xml · derivative · entry 2 Valauri Christina Rizopoulos · CIK 0002005448 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 259 Underlying: Common Stock · 259 shares Expires 2034-01-02 F1 · kind: On January 2, 2024 (the "Effective Date"), Ms. Christina Valauri (the "Reporting Person") was appointed to the Board of Directors of Precipio, Inc. (the "Company"). In connection with the Reporting Person's appointment and pursuant to the Company's 2017 Stock Option and Incentive Plan, the Company issued to the Reporting Person the option to purchase 103 and 259 shares, respectively (the "Options"), at an exercise price of $6.52 (the closing price of the Company's common stock on the Effective Date). F3 · derivative.exercise_date: The Option vests in thirty-six equal monthly installments beginning on the Effective Date. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:33 UTC | Precipio, Inc. PRPO · Entity 7207 | GrantEmployee Stock Option (right to buy) · Derivative | 103 | $0.00 Strike: $6.52 | $0.00 |
DisclosureSEC source: 0001104659-24-001395 · tm242086-2_4seq1.xml · derivative · entry 1 Valauri Christina Rizopoulos · CIK 0002005448 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103 Underlying: Common Stock · 103 shares Expires 2034-01-02 F1 · kind: On January 2, 2024 (the "Effective Date"), Ms. Christina Valauri (the "Reporting Person") was appointed to the Board of Directors of Precipio, Inc. (the "Company"). In connection with the Reporting Person's appointment and pursuant to the Company's 2017 Stock Option and Incentive Plan, the Company issued to the Reporting Person the option to purchase 103 and 259 shares, respectively (the "Options"), at an exercise price of $6.52 (the closing price of the Company's common stock on the Effective Date). F2 · derivative.exercise_date: The Option vests in twelve equal monthly installments beginning on the Effective Date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.